The British trial is only one of many. MYGN had data from other studies of patients from the USA such as study PRO-004 (performed by UCSF). Their data defiantly had specimens from non-caucasians. See this poster for example:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.